US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entrada Therapeutics, Inc.

7.08

-0.1500-2.07%

Volume:38.97K

Turnover:274.96K

Market Cap:268.71M

PE:11.67

High:7.16

Open:7.11

Low:6.97

Close:7.23

Loading ...

Overview Company News Filings

Director Kush Parmar Reports Disposal of Common Shares of Entrada Therapeutics Inc

5AM Ventures V, L.P. Reports Disposal of Common Shares of Entrada Therapeutics Inc

Entrada Therapeutics Inc. Conducted Virtual Annual Stockholders Meeting

Entrada Therapeutics Inc. Unveils Corporate Presentation Highlighting Clinical Advancements and Strategic Focus on Intracellular Therapeutics

Entrada Therapeutics Appoints Dr. Maha Radhakrishnan to Board of Directors Amidst Clinical Advancements in Duchenne Therapies

Entrada Therapeutics Appoints Maha Radhakrishnan, M.d., to Its Board of Directors

THOMSON REUTERS

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Entrada Therapeutics Company on Track to Begin Elevate-45-201 in Q3 2025

THOMSON REUTERS

Entrada Therapeutics Announces EU Authorization to Initiate Phase 1/2 Clinical Study of ENTR-601-45 for Duchenne Muscular Dystrophy

Entrada Therapeutics Receives Authorization in the European Union to Initiate Elevate-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of Entr-601-45 in Patients Living With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping

THOMSON REUTERS

Entrada Therapeutics price target lowered to $21 from $23 at Roth Capital

Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Qiagen (QGEN)

Entrada Therapeutics: Strategic Advancements in DMD Pipeline Drive Buy Rating

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)

Entrada Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Entrada Therapeutics Inc: Cash Runway Expected Into Q2 2027 With $383 Mln in Cash

THOMSON REUTERS

Entrada Therapeutics Inc expected to post a loss of 79 cents a share - Earnings Preview

North American Morning Briefing: Stock Futures Down As Oil Plunges

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TRDA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":7.08,"timestamp":1751906102754,"preClose":7.23,"halted":0,"volume":38965,"delay":0,"floatShares":21346400,"shares":37953417,"eps":0.606708,"marketStatus":"Trading","change":-0.15,"latestTime":"07-07 12:35:26 EDT","open":7.11,"high":7.16,"low":6.965,"amount":274964.86101,"amplitude":0.026971,"askPrice":7.11,"askSize":174,"bidPrice":7.08,"bidSize":101,"shortable":3,"etf":0,"ttmEps":0.606708,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751918400000},"marketStatusCode":2,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":7.23,"preHourTrading":{"tag":"盘前","latestPrice":7.12,"preClose":7.23,"latestTime":"09:29 EDT","volume":10,"amount":71.21000000000001,"timestamp":1751894999915},"postHourTrading":{"tag":"盘后","latestPrice":7.23,"preClose":7.23,"latestTime":"15:52 EDT","volume":294,"amount":2125.64,"timestamp":1751572342495},"volumeRatio":0.369795,"impliedVol":1.0955,"impliedVolPercentile":0.544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","floatShares":21346400,"roa":"0.51%","roe":"7.22%","lyrEps":1.75911,"volumeRatio":0.369795,"shares":37953417,"dividePrice":0,"high":7.16,"amplitude":0.026971,"preClose":7.23,"low":6.965,"week52Low":6.585,"pbRate":"0.64","psRate":"1.56","week52High":21.79,"institutionHeld":0,"latestPrice":7.08,"committee":-0.265455,"eps":0.606708,"divideRate":0,"volume":38965,"delay":0,"ttmEps":0.606708,"open":7.11,"prevYearClose":17.29,"prevWeekClose":7.23,"prevMonthClose":6.72,"prevQuarterClose":6.72,"fiveDayClose":6.91,"twentyDayClose":8.12,"sixtyDayClose":7.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRDA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548399878","title":"Director Kush Parmar Reports Disposal of Common Shares of Entrada Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548399878","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548399878?lang=en_us&edition=fundamental","pubTime":"2025-07-02 08:34","pubTimestamp":1751416453,"startTime":"0","endTime":"0","summary":"Kush Parmar, a Director and 10% Owner, reported a disposal of common shares of Entrada Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL74GKFY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2548605839","title":"5AM Ventures V, L.P. Reports Disposal of Common Shares of Entrada Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548605839","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548605839?lang=en_us&edition=fundamental","pubTime":"2025-07-02 08:33","pubTimestamp":1751416384,"startTime":"0","endTime":"0","summary":"5AM Ventures V, L.P., a beneficial owner, reported a disposal of common shares of Entrada Therapeutics Inc. The form was filed by more than one reporting person, including 5AM Ventures V, L.P., among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL3C0HRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2542537892","title":"Entrada Therapeutics Inc. Conducted Virtual Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542537892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542537892?lang=en_us&edition=fundamental","pubTime":"2025-06-12 04:09","pubTimestamp":1749672565,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on June 11, 2025, in a virtual-only format. During the meeting, stockholders voted on two main proposals. The first proposal was the election of three Class I director nominees to the Board of Directors. Dipal Doshi, Kush M. Parmar, M.D., Ph.D., and Mary Thistle were all elected as directors. The second proposal was the ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, which was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatheri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL6PLRpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2540238704","title":"Entrada Therapeutics Inc. Unveils Corporate Presentation Highlighting Clinical Advancements and Strategic Focus on Intracellular Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2540238704","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540238704?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:12","pubTimestamp":1748981527,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. Unveils Corporate Presentation Highlighting Clinical Advancements and Strategic Focus on Intracellular Therapeutics. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL6b4Ssl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2540759287","title":"Entrada Therapeutics Appoints Dr. Maha Radhakrishnan to Board of Directors Amidst Clinical Advancements in Duchenne Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2540759287","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540759287?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:00","pubTimestamp":1748948421,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Appoints Dr. Maha Radhakrishnan to Board of Directors Amidst Clinical Advancements in Duchenne Therapies. Entrada Therapeutics Inc. has appointed Maha Radhakrishnan, M.D., to its Board of Directors. Dr. Radhakrishnan brings extensive experience in global drug development, having previously served as Executive Partner at Sofinnova Investments and as Chief Medical Officer at Biogen. This appointment comes as Entrada continues to advance its Duchenne muscular dystrophy programs and expands its pipeline of intracellular therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on June 03, 2025, and is solely res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL43B89T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B894F039.SGD","BK4533","LU0320765992.SGD","BK4532","LU2095319765.USD","BK4585","IE00BKPKM429.USD","BK4112","LU2210149790.SGD","BK4139","TRDA","IE00BGHQF748.EUR","IE00B19Z9P08.USD","LU0234570918.USD","LU0109394709.USD","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","BIIB","NDAQ","IE00B19Z9Z06.USD"],"gpt_icon":0},{"id":"2540775340","title":"Entrada Therapeutics Appoints Maha Radhakrishnan, M.d., to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775340","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775340?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:00","pubTimestamp":1748948400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nTUA2PQJBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B894F039.SGD","LU0109394709.USD","IE00B19Z9Z06.USD","LU0234570918.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU0889565916.HKD","TRDA","BK4139","BK4532","BIIB","BK4588","BK4533","BK4585"],"gpt_icon":0},{"id":"2540959715","title":"Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2540959715","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540959715?lang=en_us&edition=fundamental","pubTime":"2025-06-03 05:03","pubTimestamp":1748898184,"startTime":"0","endTime":"0","summary":"June 2 (Reuters) - Entrada Therapeutics Inc ::*ENTRADA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 02-JUN-202520:30:00.197 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nRSDzpbZ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2540197713","title":"Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540197713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540197713?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:30","pubTimestamp":1748896200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA3T74XX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2538202134","title":"Entrada Therapeutics Company on Track to Begin Elevate-45-201 in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2538202134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538202134?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:03","pubTimestamp":1748430198,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nPLX5BE832:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2538155420","title":"Entrada Therapeutics Announces EU Authorization to Initiate Phase 1/2 Clinical Study of ENTR-601-45 for Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2538155420","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538155420?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:00","pubTimestamp":1748430027,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Announces EU Authorization to Initiate Phase 1/2 Clinical Study of ENTR-601-45 for Duchenne Muscular Dystrophy. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL15RRWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD","BK4585","TRDA","IE00B64PRP62.GBP","NDAQ","BK4588","IE00BKPKM429.USD","BK4112","BK4139","LU2210150020.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2538420527","title":"Entrada Therapeutics Receives Authorization in the European Union to Initiate Elevate-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of Entr-601-45 in Patients Living With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping","url":"https://stock-news.laohu8.com/highlight/detail?id=2538420527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538420527?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:00","pubTimestamp":1748430001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nTUA2JBVYT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2534254551","title":"Entrada Therapeutics price target lowered to $21 from $23 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2534254551","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534254551?lang=en_us&edition=fundamental","pubTime":"2025-05-12 09:00","pubTimestamp":1747011604,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on Entrada Therapeutics (TRDA) to $21 from $23 and keeps a Buy rating on the shares. The firm remains ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/entrada-therapeutics-price-target-lowered-to-21-from-23-at-roth-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/entrada-therapeutics-price-target-lowered-to-21-from-23-at-roth-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA","LENZ"],"gpt_icon":0},{"id":"2534254581","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Qiagen (QGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534254581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534254581?lang=en_us&edition=fundamental","pubTime":"2025-05-12 08:50","pubTimestamp":1747011029,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Entrada Therapeutics Inc (TRDA – Research Report) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-entrada-therapeutics-inc-trda-and-qiagen-qgen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-entrada-therapeutics-inc-trda-and-qiagen-qgen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QGEN","BK4137","BK4121","LU2433249047.HKD","LU1923622614.USD","HCSG","TRDA","BK4139","LU2125909247.SGD","LU2125909593.SGD"],"gpt_icon":0},{"id":"2534747198","title":"Entrada Therapeutics: Strategic Advancements in DMD Pipeline Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2534747198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534747198?lang=en_us&edition=fundamental","pubTime":"2025-05-09 05:57","pubTimestamp":1746741453,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on TRDA stock, giving a Buy rating today. Myles Minter has given his Buy rat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-strategic-advancements-in-dmd-pipeline-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-strategic-advancements-in-dmd-pipeline-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA","LENZ"],"gpt_icon":0},{"id":"2534157088","title":"Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534157088","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534157088?lang=en_us&edition=fundamental","pubTime":"2025-05-09 01:52","pubTimestamp":1746726745,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Entrada Therapeutics Inc (TRDA – Research Report), Galmed Pharmac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-entrada-therapeutics-inc-trda-galmed-pharmaceuticals-glmd-and-xilio-therapeutics-xlo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-entrada-therapeutics-inc-trda-galmed-pharmaceuticals-glmd-and-xilio-therapeutics-xlo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLO","BK4139","TRDA","GLMD","HCSG","BK4137"],"gpt_icon":0},{"id":"2533336151","title":"Entrada Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533336151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533336151?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:24","pubTimestamp":1746710641,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryEntrada Therapeutics Inc TRDA.OQ reported a quarterly adjusted loss of 42 cents per share for the quarter ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG1T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA"],"gpt_icon":0},{"id":"2533731188","title":"Entrada Therapeutics Inc: Cash Runway Expected Into Q2 2027 With $383 Mln in Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2533731188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533731188?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:00","pubTimestamp":1746702001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLX25EAD4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2533226584","title":"Entrada Therapeutics Inc  expected to post a loss of 79 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533226584","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533226584?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:14","pubTimestamp":1746450846,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc  expected to post a loss of79cents a share - Earnings Preview Entrada Therapeutics Inc TRDA.OQ TRDA.O is expected to show a fall in quarterly revenue when it reports  results ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD15L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA"],"gpt_icon":0},{"id":"2533788302","title":"North American Morning Briefing: Stock Futures Down As Oil Plunges","url":"https://stock-news.laohu8.com/highlight/detail?id=2533788302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533788302?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:26","pubTimestamp":1746440760,"startTime":"0","endTime":"0","summary":"Stock futures were pointing to losses early on Monday after the S&P 500 notched its longest winning streak in more than 20 years last week.Trump on Sunday described the country as being in a transition period  and left open the possibility of an economic downturn.\"Anything can happen,\" he said when asked if a recession could happen.Oil prices slumped  after OPEC+ and its allies agreed to a larger output hike for a second straight month despite weak prices and an uncertain demand outlook.Investors will be looking toward Powell's remarks  on Wednesday, following a two-day meeting of the Fed's rate-setting committee.Berkshire Hathaway shares fell 2% premarket after Warren Buffett said he plans to step down  at year-end.Warner Bros. Discovery, Netflix, Walt Disney and Paramount  all fell nearly 3% after Trump's plans for 100% tariffs on foreign-made films weighed on shares.ISM Report on Business Services PMI for April; Earnings from Palantir Technologies, Ford Motor, Vertex Pharmaceuticals","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","US6M.BOND","BCRX","CFBK","PBM","US30Y.BOND","ENSV","US7Y.BOND","HSIC","LU0266013472.USD","JBTM","ALX","LU0203345920.USD","BK4539","HYMC","LU0048573561.USD","US3Y.BOND","IE0034235303.USD","LU0234570918.USD","BK4561","ARES","JJSF","LU1074936037.SGD","US5Y.BOND","XGN","LU0683600562.USD","IE00BJLML261.HKD","FRPT","AOMR","AFG","BK4590","IE0034390439.USD","LU1571399168.USD","US12M.BOND","BK4135","BK4567","LU0130102774.USD","LU1914381329.SGD","LU0029874061.USD","US2Y.BOND","ET","CMI","IART","CNA","ESCA","BRK.B","US10Y.BOND","TRDA","FHTX","LU1941712264.USD"],"gpt_icon":1},{"id":"2532700064","title":"Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2532700064","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532700064?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:01","pubTimestamp":1746108092,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.  is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly earnings of $0.09 per share in its upcoming report, which represents a year-over-year change of +400%.Revenues are expected to be $16.2 million, up 103.3% from the year-ago quarte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eton-pharmaceuticals-inc-eton-earnings-140132614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ETON","TRDA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"TRDA","fiscalQuarterEnding":"2025/03","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-02-27","symbol":"TRDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-11-05","symbol":"TRDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-08-13","symbol":"TRDA","fiscalQuarterEnding":"2024/06","expectedEps":0.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":1.55},{"market":"US","date":"2024-05-07","symbol":"TRDA","fiscalQuarterEnding":"2024/03","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":0.68}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1733457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRDA","date":"2025-07-03","current":10.286329,"percent":0.863991,"low":-69.405148,"twenty":-9.145735,"median":-5.311468,"eighty":5.87166,"high":25.975557,"avg":-5.548888,"sd":16.443338,"marketCap":254905528},"quantilePoints":[{"date":"2021-10-29","current":-7.394936,"twenty":-17.597525,"median":-17.597525,"eighty":-11.475972,"marketCap":251013723},{"date":"2021-11-05","current":-21.790051,"twenty":-21.952046,"median":-20.803996,"eighty":-17.597525,"marketCap":739641498},{"date":"2021-11-12","current":-28.525158,"twenty":-25.58108,"median":-21.983741,"eighty":-18.485692,"marketCap":968257962},{"date":"2021-11-19","current":-28.868516,"twenty":-29.41789,"median":-24.54132,"eighty":-20.606786,"marketCap":979912918},{"date":"2021-11-26","current":-25.452541,"twenty":-28.824496,"median":-24.607351,"eighty":-21.353369,"marketCap":863961039},{"date":"2021-12-03","current":-23.533255,"twenty":-28.623764,"median":-25.505365,"eighty":-21.812942,"marketCap":798812818},{"date":"2021-12-10","current":-15.265518,"twenty":-28.187082,"median":-23.647708,"eighty":-19.069596,"marketCap":631748205},{"date":"2021-12-17","current":-11.577357,"twenty":-26.820692,"median":-22.432748,"eighty":-16.202556,"marketCap":479117339},{"date":"2021-12-23","current":-12.836913,"twenty":-26.764346,"median":-21.904504,"eighty":-14.360448,"marketCap":531242809},{"date":"2021-12-31","current":-12.912336,"twenty":-26.676305,"median":-20.53107,"eighty":-13.447835,"marketCap":534364094},{"date":"2022-01-07","current":-8.930026,"twenty":-26.218494,"median":-18.937535,"eighty":-12.769033,"marketCap":369560215},{"date":"2022-01-14","current":-6.516506,"twenty":-25.584602,"median":-17.597525,"eighty":-11.577357,"marketCap":269679075},{"date":"2022-01-21","current":-6.101682,"twenty":-25.577558,"median":-15.559666,"eighty":-10.093042,"marketCap":252512005},{"date":"2022-01-28","current":-7.021837,"twenty":-25.519451,"median":-14.360448,"eighty":-7.766209,"marketCap":290591689},{"date":"2022-02-04","current":-7.715724,"twenty":-25.463106,"median":-13.5308,"eighty":-7.379146,"marketCap":319307516},{"date":"2022-02-11","current":-8.537829,"twenty":-24.100237,"median":-13.16123,"eighty":-7.512789,"marketCap":353329529},{"date":"2022-02-18","current":-11.275667,"twenty":-23.579036,"median":-12.802973,"eighty":-7.548286,"marketCap":466632197},{"date":"2022-02-25","current":-9.126125,"twenty":-23.517408,"median":-12.086459,"eighty":-7.649352,"marketCap":377675557},{"date":"2022-03-04","current":-7.813773,"twenty":-22.862386,"median":-11.577357,"eighty":-7.720249,"marketCap":323365188},{"date":"2022-03-11","current":-6.388288,"twenty":-22.163344,"median":-11.204016,"eighty":-7.720249,"marketCap":264372890},{"date":"2022-03-18","current":-6.017184,"twenty":-21.936199,"median":-10.78542,"eighty":-7.363356,"marketCap":307827117},{"date":"2022-03-25","current":-6.255428,"twenty":-21.835832,"median":-10.117931,"eighty":-6.952448,"marketCap":320015196},{"date":"2022-04-01","current":-5.638438,"twenty":-21.46254,"median":-9.64654,"eighty":-6.638691,"marketCap":288451197},{"date":"2022-04-08","current":-4.502198,"twenty":-20.388445,"median":-9.144981,"eighty":-6.309439,"marketCap":230323437},{"date":"2022-04-14","current":-4.948141,"twenty":-19.729901,"median":-9.028075,"eighty":-6.17703,"marketCap":253137020},{"date":"2022-04-22","current":-4.107655,"twenty":-19.333718,"median":-8.726386,"eighty":-6.029276,"marketCap":210139396},{"date":"2022-04-29","current":-3.666235,"twenty":-18.754411,"median":-8.454865,"eighty":-5.912113,"marketCap":187557252},{"date":"2022-05-06","current":-3.457787,"twenty":-18.126844,"median":-8.349273,"eighty":-5.760614,"marketCap":176893461},{"date":"2022-05-13","current":-2.854496,"twenty":-17.597525,"median":-7.941992,"eighty":-5.364762,"marketCap":183969409},{"date":"2022-05-20","current":-2.883329,"twenty":-16.900041,"median":-7.813773,"eighty":-4.563286,"marketCap":185827686},{"date":"2022-05-27","current":-3.373495,"twenty":-15.618496,"median":-7.753435,"eighty":-4.36536,"marketCap":217418392},{"date":"2022-06-03","current":-3.200495,"twenty":-15.214231,"median":-7.632759,"eighty":-4.157927,"marketCap":206268731},{"date":"2022-06-10","current":-4.55566,"twenty":-14.879355,"median":-7.394936,"eighty":-4.140761,"marketCap":293607743},{"date":"2022-06-17","current":-4.11355,"twenty":-14.259382,"median":-7.131199,"eighty":-4.140761,"marketCap":265114165},{"date":"2022-06-24","current":-4.714243,"twenty":-13.855117,"median":-6.935101,"eighty":-4.15057,"marketCap":303828266},{"date":"2022-07-01","current":-5.766658,"twenty":-13.576054,"median":-6.811331,"eighty":-4.187355,"marketCap":371655372},{"date":"2022-07-08","current":-5.656131,"twenty":-13.503648,"median":-6.516506,"eighty":-4.216733,"marketCap":364531977},{"date":"2022-07-15","current":-5.209215,"twenty":-13.455377,"median":-6.350577,"eighty":-4.227922,"marketCap":335728686},{"date":"2022-07-22","current":-5.233243,"twenty":-13.218551,"median":-6.255428,"eighty":-4.255794,"marketCap":337277250},{"date":"2022-07-29","current":-6.151102,"twenty":-12.962115,"median":-6.178897,"eighty":-4.266149,"marketCap":396432396},{"date":"2022-08-05","current":-5.21402,"twenty":-12.851998,"median":-6.151102,"eighty":-4.298784,"marketCap":336038398},{"date":"2022-08-12","current":-5.083828,"twenty":-12.782609,"median":-6.05057,"eighty":-4.359782,"marketCap":395150717},{"date":"2022-08-19","current":-5.22471,"twenty":-12.238059,"median":-6.026259,"eighty":-4.396116,"marketCap":406101054},{"date":"2022-08-26","current":-5.860692,"twenty":-12.075145,"median":-5.963285,"eighty":-4.405727,"marketCap":455534002},{"date":"2022-09-02","current":-5.309239,"twenty":-11.675406,"median":-5.919443,"eighty":-4.443999,"marketCap":412671256},{"date":"2022-09-09","current":-6.005599,"twenty":-11.577357,"median":-5.919443,"eighty":-4.466633,"marketCap":466797205},{"date":"2022-09-16","current":-5.599054,"twenty":-11.396343,"median":-5.874796,"eighty":-4.487556,"marketCap":435197663},{"date":"2022-09-23","current":-6.074028,"twenty":-11.266616,"median":-5.860692,"eighty":-4.499555,"marketCap":472115940},{"date":"2022-09-30","current":-6.343716,"twenty":-11.192702,"median":-5.898062,"eighty":-4.525626,"marketCap":493078013},{"date":"2022-10-07","current":-5.961322,"twenty":-11.10672,"median":-5.888899,"eighty":-4.547138,"marketCap":463355671},{"date":"2022-10-14","current":-6.243086,"twenty":-10.903079,"median":-5.892909,"eighty":-4.553823,"marketCap":485256344},{"date":"2022-10-21","current":-7.587503,"twenty":-10.513899,"median":-5.919443,"eighty":-4.571231,"marketCap":589753842},{"date":"2022-10-28","current":-9.117079,"twenty":-10.255954,"median":-5.957297,"eighty":-4.615058,"marketCap":708643211},{"date":"2022-11-04","current":-8.909464,"twenty":-10.100584,"median":-5.973297,"eighty":-4.663727,"marketCap":692505938},{"date":"2022-11-11","current":-6.743676,"twenty":-9.96784,"median":-6.011392,"eighty":-4.695302,"marketCap":596370284},{"date":"2022-11-18","current":-6.332606,"twenty":-9.758166,"median":-6.033802,"eighty":-4.710399,"marketCap":560017708},{"date":"2022-11-25","current":-5.226969,"twenty":-9.516814,"median":-6.017184,"eighty":-4.72039,"marketCap":462241813},{"date":"2022-12-02","current":-6.488529,"twenty":-9.262707,"median":-6.011392,"eighty":-4.755372,"marketCap":573806616},{"date":"2022-12-09","current":-6.757851,"twenty":-9.16356,"median":-6.033802,"eighty":-4.809238,"marketCap":597623821},{"date":"2022-12-16","current":-7.505574,"twenty":-9.145735,"median":-6.049635,"eighty":-4.867597,"marketCap":663747905},{"date":"2022-12-23","current":-5.304931,"twenty":-9.135788,"median":-6.033802,"eighty":-4.931786,"marketCap":469136267},{"date":"2022-12-30","current":-4.791093,"twenty":-9.127349,"median":-6.017184,"eighty":-4.849836,"marketCap":423695546},{"date":"2023-01-06","current":-5.04624,"twenty":-9.126125,"median":-6.001574,"eighty":-4.798181,"marketCap":446259214},{"date":"2023-01-13","current":-4.858424,"twenty":-9.117079,"median":-5.963335,"eighty":-4.832074,"marketCap":429649847},{"date":"2023-01-20","current":-4.737938,"twenty":-9.004373,"median":-5.936357,"eighty":-4.79343,"marketCap":418994782},{"date":"2023-01-27","current":-4.273712,"twenty":-8.93926,"median":-5.907226,"eighty":-4.785423,"marketCap":377941441},{"date":"2023-02-03","current":-5.10294,"twenty":-8.913576,"median":-5.876808,"eighty":-4.726537,"marketCap":451273363},{"date":"2023-02-10","current":-5.73372,"twenty":-8.859542,"median":-5.853158,"eighty":-4.736273,"marketCap":507055765},{"date":"2023-02-17","current":-3.919341,"twenty":-8.845264,"median":-5.829192,"eighty":-4.699967,"marketCap":346603013},{"date":"2023-02-24","current":-3.926429,"twenty":-8.842391,"median":-5.815955,"eighty":-4.628083,"marketCap":347229782},{"date":"2023-03-03","current":-3.766962,"twenty":-8.772142,"median":-5.776163,"eighty":-4.547138,"marketCap":333127489},{"date":"2023-03-10","current":-4.254453,"twenty":-8.615439,"median":-5.76082,"eighty":-4.499555,"marketCap":402539289},{"date":"2023-03-17","current":-5.429059,"twenty":-8.539287,"median":-5.747436,"eighty":-4.511816,"marketCap":513675855},{"date":"2023-03-24","current":-5.271746,"twenty":-8.488051,"median":-5.734949,"eighty":-4.524607,"marketCap":498791493},{"date":"2023-03-31","current":-5.068986,"twenty":-8.454865,"median":-5.728214,"eighty":-4.53629,"marketCap":479607205},{"date":"2023-04-06","current":-4.883706,"twenty":-8.451848,"median":-5.696978,"eighty":-4.543209,"marketCap":462076735},{"date":"2023-04-14","current":-5.932462,"twenty":-8.421679,"median":-5.680564,"eighty":-4.551986,"marketCap":561305812},{"date":"2023-04-21","current":-5.257762,"twenty":-8.349273,"median":-5.670547,"eighty":-4.55566,"marketCap":497468439},{"date":"2023-04-28","current":-4.805367,"twenty":-8.340215,"median":-5.658534,"eighty":-4.562088,"marketCap":454664626},{"date":"2023-05-05","current":-4.191543,"twenty":-8.062667,"median":-5.64652,"eighty":-4.528859,"marketCap":396587028},{"date":"2023-05-12","current":-5.064425,"twenty":-7.979703,"median":-5.633268,"eighty":-4.502198,"marketCap":403224467},{"date":"2023-05-19","current":-5.277006,"twenty":-7.913544,"median":-5.617686,"eighty":-4.518228,"marketCap":420149939},{"date":"2023-05-26","current":-4.970025,"twenty":-7.90428,"median":-5.592298,"eighty":-4.528859,"marketCap":395708454},{"date":"2023-06-02","current":-4.76989,"twenty":-7.868078,"median":-5.581432,"eighty":-4.538767,"marketCap":379773885},{"date":"2023-06-09","current":-6.116634,"twenty":-7.822824,"median":-5.586978,"eighty":-4.549103,"marketCap":487000254},{"date":"2023-06-16","current":-6.016566,"twenty":-7.801706,"median":-5.597041,"eighty":-4.554742,"marketCap":479032969},{"date":"2023-06-23","current":-6.667006,"twenty":-7.789638,"median":-5.618244,"eighty":-4.559517,"marketCap":530820317},{"date":"2023-06-30","current":-6.279244,"twenty":-7.759469,"median":-5.62503,"eighty":-4.565397,"marketCap":499947091},{"date":"2023-07-07","current":-6.658667,"twenty":-7.721758,"median":-5.636859,"eighty":-4.57261,"marketCap":530156377},{"date":"2023-07-14","current":-6.737887,"twenty":-7.69008,"median":-5.655758,"eighty":-4.584244,"marketCap":536463810},{"date":"2023-07-21","current":-7.325784,"twenty":-7.579961,"median":-5.662109,"eighty":-4.599308,"marketCap":583271606},{"date":"2023-07-28","current":-6.971378,"twenty":-7.548286,"median":-5.680564,"eighty":-4.620996,"marketCap":555054140},{"date":"2023-08-04","current":-6.024905,"twenty":-7.53565,"median":-5.7162,"eighty":-4.635607,"marketCap":479696910},{"date":"2023-08-11","current":-6.317571,"twenty":-7.508508,"median":-5.728214,"eighty":-4.646146,"marketCap":520365665},{"date":"2023-08-18","current":-6.081084,"twenty":-7.503806,"median":-5.74007,"eighty":-4.685973,"marketCap":500886743},{"date":"2023-08-25","current":-6.565311,"twenty":-7.485744,"median":-5.747894,"eighty":-4.706554,"marketCap":540771554},{"date":"2023-09-01","current":-5.939851,"twenty":-7.432417,"median":-5.767385,"eighty":-4.717317,"marketCap":489253674},{"date":"2023-09-08","current":-5.90757,"twenty":-7.394936,"median":-5.767385,"eighty":-4.729611,"marketCap":486594686},{"date":"2023-09-15","current":-6.125472,"twenty":-7.334123,"median":-5.776163,"eighty":-4.737938,"marketCap":504542851},{"date":"2023-09-22","current":-5.491941,"twenty":-7.325784,"median":-5.777303,"eighty":-4.750864,"marketCap":452360224},{"date":"2023-09-29","current":-6.528994,"twenty":-7.315985,"median":-5.798618,"eighty":-4.757855,"marketCap":537780193},{"date":"2023-10-06","current":-5.891429,"twenty":-7.305739,"median":-5.815592,"eighty":-4.762744,"marketCap":485265193},{"date":"2023-10-13","current":-5.245793,"twenty":-7.264602,"median":-5.81239,"eighty":-4.76989,"marketCap":432085446},{"date":"2023-10-20","current":-5.911605,"twenty":-7.242394,"median":-5.819157,"eighty":-4.778229,"marketCap":486927060},{"date":"2023-10-27","current":-5.61098,"twenty":-7.227384,"median":-5.819157,"eighty":-4.783375,"marketCap":462165240},{"date":"2023-11-03","current":-6.323198,"twenty":-7.199866,"median":-5.83392,"eighty":-4.792261,"marketCap":520829149},{"date":"2023-11-10","current":-24.667435,"twenty":-7.289284,"median":-5.845821,"eighty":-4.795681,"marketCap":537010063},{"date":"2023-11-17","current":-23.534356,"twenty":-7.370611,"median":-5.860692,"eighty":-4.801055,"marketCap":512342934},{"date":"2023-11-24","current":-17.593348,"twenty":-7.503806,"median":-5.888899,"eighty":-4.80845,"marketCap":383007177},{"date":"2023-12-01","current":-19.859506,"twenty":-7.579961,"median":-5.902072,"eighty":-4.82304,"marketCap":432341435},{"date":"2023-12-08","current":-20.456669,"twenty":-7.795672,"median":-5.911605,"eighty":-4.834509,"marketCap":445341678},{"date":"2023-12-15","current":-21.421317,"twenty":-7.911691,"median":-5.925612,"eighty":-4.846375,"marketCap":466342072},{"date":"2023-12-22","current":-22.600332,"twenty":-8.347461,"median":-5.932462,"eighty":-4.855589,"marketCap":492009220},{"date":"2023-12-29","current":-25.126791,"twenty":-8.454865,"median":-5.939851,"eighty":-4.857715,"marketCap":547010250},{"date":"2024-01-05","current":-21.5285,"twenty":-8.540017,"median":-5.941515,"eighty":-4.868537,"marketCap":468675449},{"date":"2024-01-12","current":-24.698059,"twenty":-8.846163,"median":-5.963335,"eighty":-4.891549,"marketCap":537676742},{"date":"2024-01-19","current":-22.952505,"twenty":-8.966963,"median":-5.978768,"eighty":-4.905676,"marketCap":499676030},{"date":"2024-01-26","current":-22.814698,"twenty":-9.138499,"median":-5.992309,"eighty":-4.915832,"marketCap":496675974},{"date":"2024-02-02","current":-22.615644,"twenty":-9.581677,"median":-6.004236,"eighty":-4.91911,"marketCap":492342559},{"date":"2024-02-09","current":-22.217535,"twenty":-10.307241,"median":-6.016566,"eighty":-4.921856,"marketCap":483675730},{"date":"2024-02-16","current":-22.99844,"twenty":-11.237955,"median":-6.024748,"eighty":-4.926434,"marketCap":500676049},{"date":"2024-02-23","current":-20.272926,"twenty":-11.577357,"median":-6.028302,"eighty":-4.929152,"marketCap":441341603},{"date":"2024-03-01","current":-20.257614,"twenty":-12.836913,"median":-6.037413,"eighty":-4.93164,"marketCap":441008264},{"date":"2024-03-08","current":-19.262342,"twenty":-13.485547,"median":-6.058862,"eighty":-4.948141,"marketCap":419341191},{"date":"2024-03-15","current":-61.321385,"twenty":-15.009082,"median":-6.081084,"eighty":-4.952685,"marketCap":409933456},{"date":"2024-03-22","current":-65.487505,"twenty":-17.593348,"median":-6.089351,"eighty":-4.961191,"marketCap":437783972},{"date":"2024-03-28","current":-69.405148,"twenty":-18.101359,"median":-6.099956,"eighty":-4.961191,"marketCap":463973412},{"date":"2024-04-05","current":-66.890118,"twenty":-18.959167,"median":-6.113366,"eighty":-4.968258,"marketCap":447160438},{"date":"2024-04-12","current":-64.133258,"twenty":-19.427711,"median":-6.12749,"eighty":-4.972184,"marketCap":428730832},{"date":"2024-04-19","current":-57.740708,"twenty":-19.862568,"median":-6.151102,"eighty":-4.983342,"marketCap":385996632},{"date":"2024-04-26","current":-59.922347,"twenty":-20.184117,"median":-6.16971,"eighty":-4.990199,"marketCap":400580888},{"date":"2024-05-03","current":-65.74005,"twenty":-20.444419,"median":-6.184272,"eighty":-4.992718,"marketCap":439472236},{"date":"2024-05-10","current":19.415556,"twenty":-20.444419,"median":-6.175043,"eighty":-4.972184,"marketCap":455974329},{"date":"2024-05-17","current":20.21327,"twenty":-20.380109,"median":-6.165519,"eighty":-4.951776,"marketCap":474708650},{"date":"2024-05-24","current":20.307914,"twenty":-20.2913,"median":-6.137664,"eighty":-4.92478,"marketCap":476931366},{"date":"2024-05-31","current":21.13267,"twenty":-20.263739,"median":-6.121053,"eighty":-4.910399,"marketCap":496300749},{"date":"2024-06-07","current":21.36252,"twenty":-20.202491,"median":-6.101682,"eighty":-4.850628,"marketCap":501698774},{"date":"2024-06-14","current":22.241358,"twenty":-20.073872,"median":-6.099956,"eighty":-4.811533,"marketCap":522338281},{"date":"2024-06-21","current":19.523721,"twenty":-19.926878,"median":-6.084547,"eighty":-4.791677,"marketCap":458514576},{"date":"2024-06-28","current":21.190193,"twenty":-19.908503,"median":-6.084547,"eighty":-4.774893,"marketCap":497651675},{"date":"2024-07-05","current":21.220101,"twenty":-19.884004,"median":-6.074028,"eighty":-4.75366,"marketCap":498354077},{"date":"2024-07-12","current":25.975557,"twenty":-19.868693,"median":-6.049635,"eighty":-4.708476,"marketCap":610035963},{"date":"2024-07-15","current":25.646563,"twenty":-19.86563,"median":-6.041344,"eighty":-4.695302,"marketCap":602309543},{"date":"2024-08-02","current":23.867006,"twenty":-19.862568,"median":-6.039378,"eighty":-4.672517,"marketCap":560516636},{"date":"2024-08-09","current":21.608912,"twenty":-19.826255,"median":-6.030346,"eighty":-4.59214,"marketCap":507485300},{"date":"2024-08-16","current":5.477968,"twenty":-19.64186,"median":-6.024748,"eighty":-4.554742,"marketCap":572140896},{"date":"2024-08-23","current":5.427433,"twenty":-19.500935,"median":-6.016566,"eighty":-4.515022,"marketCap":566862843},{"date":"2024-08-30","current":5.895722,"twenty":-19.427711,"median":-6.004236,"eighty":-4.471291,"marketCap":615772797},{"date":"2024-09-06","current":5.184866,"twenty":-19.32359,"median":-5.996942,"eighty":-4.404766,"marketCap":541528191},{"date":"2024-09-13","current":5.00631,"twenty":-19.188845,"median":-5.984239,"eighty":-4.33112,"marketCap":522879072},{"date":"2024-09-20","current":5.053476,"twenty":-19.038789,"median":-5.963335,"eighty":-4.288277,"marketCap":527805255},{"date":"2024-09-27","current":5.312888,"twenty":-18.96223,"median":-5.941515,"eighty":-4.265242,"marketCap":554899258},{"date":"2024-10-04","current":5.53861,"twenty":-18.944963,"median":-5.936157,"eighty":-4.226961,"marketCap":578474559},{"date":"2024-10-11","current":5.326364,"twenty":-18.856806,"median":-5.931781,"eighty":-4.189868,"marketCap":556306738},{"date":"2024-10-18","current":5.939519,"twenty":-18.609029,"median":-5.915524,"eighty":-4.126724,"marketCap":620347109},{"date":"2024-10-25","current":5.673369,"twenty":-18.19595,"median":-5.907226,"eighty":-4.100192,"marketCap":592549366},{"date":"2024-10-31","current":5.80476,"twenty":-17.843071,"median":-5.891429,"eighty":-4.019982,"marketCap":606272302},{"date":"2024-11-08","current":12.390042,"twenty":-17.597525,"median":-5.862704,"eighty":-3.976074,"marketCap":680845207},{"date":"2024-11-15","current":12.267624,"twenty":-17.595854,"median":-5.851076,"eighty":-3.881511,"marketCap":674118187},{"date":"2024-11-22","current":11.629759,"twenty":-17.593348,"median":-5.835599,"eighty":-3.819187,"marketCap":639066874},{"date":"2024-11-29","current":12.815285,"twenty":-17.245441,"median":-5.821992,"eighty":-3.767275,"marketCap":704212749},{"date":"2024-12-06","current":13.092338,"twenty":-15.736155,"median":-5.81239,"eighty":-3.495412,"marketCap":719437057},{"date":"2024-12-13","current":11.67486,"twenty":-15.214231,"median":-5.797942,"eighty":-3.367358,"marketCap":641545250},{"date":"2024-12-20","current":11.133642,"twenty":-14.879355,"median":-5.778442,"eighty":-3.167818,"marketCap":611804741},{"date":"2024-12-27","current":11.430023,"twenty":-14.360448,"median":-5.768112,"eighty":-2.950607,"marketCap":628091210},{"date":"2025-01-03","current":11.249617,"twenty":-13.956183,"median":-5.754982,"eighty":-2.907357,"marketCap":618177707},{"date":"2025-01-10","current":10.450675,"twenty":-13.687679,"median":-5.750196,"eighty":-2.871796,"marketCap":574275052},{"date":"2025-01-17","current":8.079622,"twenty":-13.52175,"median":-5.745698,"eighty":4.66739,"marketCap":443983302},{"date":"2025-01-24","current":8.324459,"twenty":-13.470462,"median":-5.734949,"eighty":4.930845,"marketCap":457437341},{"date":"2025-01-31","current":8.614397,"twenty":-13.333193,"median":-5.728214,"eighty":5.00631,"marketCap":473369756},{"date":"2025-02-07","current":8.685271,"twenty":-13.061672,"median":-5.704997,"eighty":5.067626,"marketCap":477264347},{"date":"2025-02-14","current":8.13761,"twenty":-12.882167,"median":-5.680564,"eighty":5.23877,"marketCap":447169785},{"date":"2025-02-21","current":8.421105,"twenty":-12.823337,"median":-5.663281,"eighty":5.326364,"marketCap":462748146},{"date":"2025-02-28","current":6.463236,"twenty":-12.636289,"median":-5.655945,"eighty":5.420021,"marketCap":424156296},{"date":"2025-03-07","current":5.656685,"twenty":-12.097773,"median":-5.638438,"eighty":5.496161,"marketCap":371225587},{"date":"2025-03-14","current":5.873832,"twenty":-11.969554,"median":-5.62503,"eighty":5.544674,"marketCap":385476089},{"date":"2025-03-21","current":5.651256,"twenty":-11.577357,"median":-5.617686,"eighty":5.571626,"marketCap":370869324},{"date":"2025-03-28","current":5.406965,"twenty":-11.517019,"median":-5.599973,"eighty":5.615422,"marketCap":354837509},{"date":"2025-04-04","current":4.353801,"twenty":-11.27265,"median":-5.589567,"eighty":5.571626,"marketCap":285722573},{"date":"2025-04-11","current":4.261514,"twenty":-11.237955,"median":-5.571525,"eighty":5.568257,"marketCap":279666109},{"date":"2025-04-17","current":4.266943,"twenty":-11.147449,"median":-5.559289,"eighty":5.565562,"marketCap":280022372},{"date":"2025-04-25","current":4.864097,"twenty":-11.079568,"median":-5.509464,"eighty":5.565562,"marketCap":319211253},{"date":"2025-05-02","current":4.962433,"twenty":-10.78542,"median":-5.491157,"eighty":5.545348,"marketCap":325664639},{"date":"2025-05-09","current":12.517294,"twenty":-10.332885,"median":-5.478703,"eighty":5.545348,"marketCap":310191070},{"date":"2025-05-16","current":11.552558,"twenty":-10.204667,"median":-5.459354,"eighty":5.5723,"marketCap":286283941},{"date":"2025-05-23","current":10.841194,"twenty":-10.031195,"median":-5.452073,"eighty":5.656685,"marketCap":268655619},{"date":"2025-05-30","current":11.239558,"twenty":-9.946722,"median":-5.429059,"eighty":5.695138,"marketCap":278527479},{"date":"2025-06-06","current":11.552558,"twenty":-9.702353,"median":-5.399443,"eighty":5.718514,"marketCap":286283941},{"date":"2025-06-13","current":11.168421,"twenty":-9.387087,"median":-5.353381,"eighty":5.773165,"marketCap":276764647},{"date":"2025-06-20","current":10.001784,"twenty":-9.232949,"median":-5.335361,"eighty":5.826994,"marketCap":247854200},{"date":"2025-06-27","current":9.987556,"twenty":-9.158624,"median":-5.321012,"eighty":5.856345,"marketCap":247501633},{"date":"2025-07-03","current":10.286329,"twenty":-9.145735,"median":-5.311468,"eighty":5.87166,"marketCap":254905528}],"updateTime":1751904268779}}}